Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA double helix structure via intercalation refers to the complex formed when planar aromatic molecules insert themselves between adjacent base pairs in the DNA double helix. This process, known as intercalation, does not break hydrogen bonds but distorts the DNA structure, causing unwinding, lengthening, and altered spacing between phosphate groups. Intercalation can inhibit replication and transcription and is exploited by some drugs, such as doxorubicin, for therapeutic purposes. The interaction involves various forces, including π-stacking, van der Waals forces, and hydrophobic effects. This altered DNA structure represents a molecular target for specific drug design and potential therapeutic interventions, especially in cancer.
Insertion between base pairs of DNA, causing unwinding, lengthening, and distortion of the double helix, ultimately inhibiting replication and transcription.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Double Helix Structure via Intercalation (DNA Intercalation).